• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Chagas disease in European countries: the challenge of a surveillance system

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]


Eurosurveillance, Volume 16, Issue 37, 15 September 2011
Surveillance and outbreak reports

Chagas disease in European countries: the challenge of a surveillance system

L Basile<SUP>1</SUP>, J M Jans?<SUP>2</SUP>, Y Carlier<SUP>3</SUP>, D D Salamanca<SUP>4</SUP>, A Angheben<SUP>5</SUP>, A Bartoloni<SUP>6</SUP>, J Seixas<SUP>7</SUP>, T Van Gool<SUP>8</SUP>, C Ca?avate<SUP>9</SUP>, M Flores-Ch?vez<SUP>9</SUP>, Y Jackson<SUP>10</SUP>, P L Chiodini<SUP>11</SUP>, P Albajar-Vi?as ()<SUP>12</SUP>, Working Group on Chagas Disease<SUP>13</SUP>
  1. Department of Health, Generalitat of Catalonia, Barcelona, Spain
  2. Directorate General of Public Health and Foreign Healthcare, Ministry of Health, Social Affairs and Equality, Madrid, Spain
  3. Faculty of Medicine, Free University of Bruxelles, Brussels, Belgium
  4. French Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS), Saint Maurice, France
  5. Centre for Tropical Diseases, COHEMI network, Hospital S. Cuore, Don Calabria, Negrar, Verona, Italy
  6. University Hospital Centre Careggi, COHEMI network, Firenze, Italy
  7. Clinical unit of Tropical Diseases, Institute of Hygiene and Tropical Medicine, New University of Lisbon, Lisbon, Portugal
  8. Department of Medical Microbiology, University of Amsterdam, Amsterdam, the Netherlands
  9. National Centre of Microbiology, Instituto de Salud Carlos III, Madrid, Spain
  10. Division of primary care medicine, Geneva University Hospitals and University of Geneva, Geneva, Switzerland
  11. Hospital for Tropical Diseases, London, United Kingdom
  12. World Health Organization (WHO) Programme on Control of Chagas disease, Department of Control of Neglected Tropical Diseases, WHO, Geneva, Switzerland
  13. The members of this group are listed at the end of the article
<HR>
Citation style for this article: Basile L, Jans? JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, Seixas J, Van Gool T, Ca?avate C, Flores-Ch?vez M, Jackson Y, Chiodini PL, Albajar-Vi?as P, Working Group on Chagas Disease. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16(37):pii=19968. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19968
Date of submission: 28 February 2011
<HR>A study of aggregate data collected from the literature and official sources was undertaken to estimate expected and observed prevalence of Trypanosoma cruzi infection, annual incidence of congenital transmission and rate of underdiagnosis of Chagas disease among Latin American migrants in the nine European countries with the highest prevalence of Chagas disease. Formal and informal data sources were used to estimate the population from endemic countries resident in Europe in 2009, diagnosed cases of Chagas disease and births from mothers originating from endemic countries. By 2009, 4,290 cases had been diagnosed in Europe, compared with an estimated 68,000 to 122,000 expected cases. The expected prevalence was very high in undocumented migrants (on average 45% of total expected cases) while the observed prevalence rate was 1.3 cases per 1,000 resident migrants from endemic countries. An estimated 20 to 183 babies with congenital Chagas disease are born annually in the study countries. The annual incidence rate of congenital transmission per 1,000 pregnancies in women from endemic countries was between none and three cases. The index of underdiagnosis of T. cruzi infection was between 94% and 96%. Chagas disease is a public health challenge in the studied European countries. Urgent measures need to be taken to detect new cases of congenital transmission and take care of the existing cases with a focus on migrants without legal residency permit and potential difficulty accessing care.
- -------
 
Back
Top